Pharmacologic Management of Agitation in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|17|1-2|65-77

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.17, Iss.1-2, 2003-12, pp. : 65-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 2, 2006-12 ,pp. : 116-119

Karger

Access to resources Recommend Favorite

Agitation in Alzheimer’s Disease Is a Manifestation of Frontal Lobe Dysfunction

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 14-20

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 2, 2011-02 ,pp. : 158-164

Karger

Access to resources Recommend Favorite

Perseveration in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 2, 2007-12 ,pp. : 109-114

Karger

Access to resources Recommend Favorite

Agraphia in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 226-230

Karger

Access to resources Recommend Favorite